Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cell factor and chronic myeloid leukemia CD34+ cells.

S Moore1, L A McDiarmid, T P Hughes

  • 1Division of Haematology, Hanson Centre for Cancer Research, IMVS, Adelaide, Australia. sarah.moore@imvs.sa.gov.au

Leukemia & Lymphoma
|June 1, 2000
PubMed
Summary

Chronic myeloid leukemia (CML) involves abnormal cell growth due to dysregulated responses to Stem Cell Factor (SCF). This suggests activated accessory pathways, not increased SCF sensitivity, drive leukemic cell proliferation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Argas persicus sensu stricto does occur in Australia.

Parasitology research·2004
Same author

Is there synchronicity in nitrogen input and output fluxes at the Noland Divide Watershed, a small N-saturated forested catchment in the Great Smoky Mountains National Park?

TheScientificWorldJournal·2003
Same author

Recrudescent herpes labialis during and prior to early pregnancy.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2003
Same author

Identification of novel CLN2 mutations shows Canadian specific NCL2 alleles.

Journal of medical genetics·2002
Same author

Use of the metastable atom bombardment (MAB) ion source for the elimination of PCDE interference in PCDD/PCDF analysis.

Chemosphere·2002
Same author

Prescribing patterns in schizophrenic inpatients in Trinidad and Tobago.

Pharmacoepidemiology and drug safety·2002

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Normal hematopoiesis relies on balanced regulatory signals.
  • Chronic myeloid leukemia (CML) exhibits dysregulated hematopoiesis, leading to leukemic cell overgrowth.
  • Abnormal responses to Stem Cell Factor (SCF) may contribute to CML proliferation.

Purpose of the Study:

  • To investigate the abnormal response of CML CD34+ cells to SCF.
  • To understand the role of SCF in leukemic progenitor proliferation and adhesion.
  • To identify key determinants of aberrant SCF response in CML.

Main Methods:

  • Culturing CML CD34+ cells with SCF.
  • Assessing proliferation and adhesion to fibronectin.
  • Comparing CML cell response to normal hematopoietic progenitors.

Related Experiment Videos

Main Results:

  • CML CD34+ cells proliferate in SCF alone, unlike normal cells.
  • SCF-induced proliferation and adhesion are uncoupled in CML.
  • CML cells do not show increased sensitivity to SCF but have activated accessory pathways.

Conclusions:

  • The abnormal proliferation in CML is linked to dysregulated SCF response and activated accessory pathways.
  • Expression of bcr-abl may be essential for SCF-driven proliferation in myeloproliferative disorders.
  • Further research into SCF response determinants could clarify CML pathogenesis.